![Low-Dose Busulfan Reduces Human CD34+ Cell Doses Required for Engraftment in c-kit Mutant Immunodeficient Mice: Molecular Therapy - Methods & Clinical Development Low-Dose Busulfan Reduces Human CD34+ Cell Doses Required for Engraftment in c-kit Mutant Immunodeficient Mice: Molecular Therapy - Methods & Clinical Development](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/900dca3b-e32f-4070-b136-bfdac0604507/gr1_lrg.jpg)
Low-Dose Busulfan Reduces Human CD34+ Cell Doses Required for Engraftment in c-kit Mutant Immunodeficient Mice: Molecular Therapy - Methods & Clinical Development
![Enhanced Reconstitution of Human Erythropoiesis and Thrombopoiesis in an Immunodeficient Mouse Model with KitWv Mutations - ScienceDirect Enhanced Reconstitution of Human Erythropoiesis and Thrombopoiesis in an Immunodeficient Mouse Model with KitWv Mutations - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2213671116301072-fx1.jpg)
Enhanced Reconstitution of Human Erythropoiesis and Thrombopoiesis in an Immunodeficient Mouse Model with KitWv Mutations - ScienceDirect
![Moving beyond the mousetrap: current and emerging humanized mouse and rat models for investigating prevention and cure strategies against HIV infection and associated pathologies | Retrovirology | Full Text Moving beyond the mousetrap: current and emerging humanized mouse and rat models for investigating prevention and cure strategies against HIV infection and associated pathologies | Retrovirology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12977-020-00515-3/MediaObjects/12977_2020_515_Fig1_HTML.png)